The content on this site is intended for healthcare professionals only
Prof Kwok-Leung Cheung speaks to ecancer at the SIOG 2019 meeting in Geneva about the occurrence of breast cancer in elderly patients.
Prof Cheung explains that these patients are commonly diagnosed late and the challenges associated with early, operable primary breast cancer.
He also describes his work, which focuses on finding the optimal treatment for these patients to avoid over- and under-treatment.
This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.
Sacituzumab govitecan plus pembrolizumab improves PFS across biomarker subgroups in metastatic triple-negative breast cancer
Sacituzumab govitecan improves PFS in first-line metastatic TNBC patients unable to receive PD-(L)1 inhibitors
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The advantages of IORT for early breast cancer treatment
The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer
Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC
